The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
Open accessAbstract
It is essential to acknowledge the efforts made thus far to manage or eliminate various disease burden faced by humankind. However, the rising global trends of the so-called incurable diseases continue to put pressure on Pharma industries and other drug discovery platforms. In the past, drugs with more than one target were deemed as undesirable options with interest being on the one-drug-single target. Despite the successes of the single-target drugs, it is currently beyond doubt that these drugs have limited efficacy against complex diseases in which the pathogenesis is dependent on a set of biochemical events and several bioreceptors operating concomitantly. Different approaches have thus been proposed to come up with effective drugs to combat even the complex diseases. In the past, the focus was on producing drugs from screening plant compounds; today, we talk about combination therapy and multi-targeting drugs. The multi-target drugs have recently attracted much attention as promising tools to fight against most challenging diseases, and thus a new research focus area. This review will discuss the potential impact of multi-target drug approach on various complex diseases with focus on malaria, tuberculosis (TB), diabetes and neurodegenerative diseases as the main representatives of multifactorial diseases. We will also discuss alternative ideas to solve the current problems bearing in mind the fourth industrial revolution on drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Climate Change 2013 – The Physical Science Basis · doi:10.1017/cbo9781107415324.004 · Cited by 23,880
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Guo, J., Huang, F., Liu, J., Chen, Y., Wang, W., Cao, B., Zou, Z., Liu, S., Pan, J., Bao, C., et al. (2016) · Scientific Reports · doi:10.1038/srep21230 · Cited by 2,148
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Synthesis of clathrate cerium superhydride CeH9 at 80-100 GPa with atomic hydrogen sublattice
Salke, N. P., Davari Esfahani, M. M., Zhang, Y., Kruglov, I. A., Zhou, J., Wang, Y., Greenberg, E., Prakapenka, V. B., Liu, J., Oganov, A. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12326-y · Cited by 1,004
Lipsewers, Y. A., Hopmans, E. C., Meysman, F. J. R., Sinninghe Damsté, J. S., & Villanueva, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01661 · Cited by 937
Konecny, G. E., Pegram, M. D., Venkatesan, N., Finn, R., Yang, G., Rahmeh, M., Untch, M., Rusnak, D. W., Spehar, G., Mullin, R. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1182 · Cited by 914
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 718
Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000316 · Cited by 678
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Shifting from the single to the multitarget paradigm in drug discovery
Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 483
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity
Saturnino, C., Grande, F., Aquaro, S., Caruso, A., Iacopetta, D., Bonomo, M., Longo, P., Schols, D., & Sinicropi, M. (2018) · Molecules · doi:10.3390/molecules23020286 · Cited by 482
Saturnino, C., Popolo, A., Ramunno, A., Adesso, S., Pecoraro, M., Plutino, M., Rizzato, S., Albinati, A., Marzocco, S., Sala, M., et al. (2017) · Molecules · doi:10.3390/molecules22040616 · Cited by 449
León, R., Garcia, A. G., & Marco‐Contelles, J. (2013) · Medicinal Research Reviews · doi:10.1002/med.20248 · Cited by 440
Qaseem, A., Humphrey, L. L., Sweet, D. E., Starkey, M., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-3-201202070-00011 · Cited by 400
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
Youdim, M. B. H., & Buccafusco, J. J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.007 · Cited by 380
Pirnay, J.-P., Verbeken, G., Ceyssens, P.-J., Huys, I., De Vos, D., Ameloot, C., & Fauconnier, A. (2018) · Viruses · doi:10.3390/v10020064 · Cited by 347
Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis
Zhou, P., Xie, W., He, S., Sun, Y., Meng, X., Sun, G., & Sun, X. (2019) · Cells · doi:10.3390/cells8030204 · Cited by 307
Bacteriophages and their implications on future biotechnology: a review
Haq, I. U., Chaudhry, W. N., Akhtar, M. N., Andleeb, S., & Qadri, I. (2012) · Virology Journal · doi:10.1186/1743-422x-9-9 · Cited by 304
Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V., & Park, M. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219002110 · Cited by 285
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Davidson, M. B., Einhorn, D., Timothy Garvey, W., et al. (2013) · Endocrine Practice · doi:10.4158/ep13176.cs · Cited by 280
Flinn, I. W., O’Brien, S., Kahl, B., Patel, M., Oki, Y., Foss, F. F., Porcu, P., Jones, J., Burger, J. A., Jain, N., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786566 · Cited by 252
The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
Carreiras, M., Mendes, E., Perry, M., Francisco, A., & Marco-Contelles, J. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990135 · Cited by 240
What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
Pooran, A., Pieterson, E., Davids, M., Theron, G., & Dheda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054587 · Cited by 231
Multitarget Drug Discovery and Polypharmacology
Bolognesi, M. L., & Cavalli, A. (2016) · ChemMedChem · doi:10.1002/cmdc.201600161 · Cited by 231
Polypharmacology in a Single Drug: Multitarget Drugs
L. Bolognesi, M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130004 · Cited by 230
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
Li, K., Schurig-Briccio, L. A., Feng, X., Upadhyay, A., Pujari, V., Lechartier, B., Fontes, F. L., Yang, H., Rao, G., Zhu, W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500131s · Cited by 223
Qaseem, A., Barry, M. J., Humphrey, L. L., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-1860 · Cited by 207
Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202
Schuch, R., Lee, H. M., Schneider, B. C., Sauve, K. L., Law, C., Khan, B. K., Rotolo, J. A., Horiuchi, Y., Couto, D. E., Raz, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit637 · Cited by 196
Activation of natural killer cells by heat shock protein 70
Multhoff, G. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902902001 · Cited by 182
The Role of Heat Shock Proteins in Antigen Cross Presentation
Murshid, A., Gong, J., & Calderwood, S. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00063 · Cited by 182
Insulin therapy and hypoglycemia
McCall, A. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.001 · Cited by 177
Pekas, A., Palevsky, E., Sumner, J. C., Perotti, M. A., Nesvorna, M., & Hubert, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00046-6 · Cited by 177
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
Kumar, K., Kumar, A., Keegan, R. M., & Deshmukh, R. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.053 · Cited by 177
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
Cefalo, C. M. A., Cinti, F., Moffa, S., Impronta, F., Sorice, G. P., Mezza, T., Pontecorvi, A., & Giaccari, A. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0828-y · Cited by 174
Simone Tranches Dias, K., & Viegas, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511153200 · Cited by 173
Love, M., Bhandari, D., Dobson, R., & Billington, C. (2018) · Antibiotics · doi:10.3390/antibiotics7010017 · Cited by 173
Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent
Schuch, R., Khan, B. K., Raz, A., Rotolo, J. A., & Wittekind, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02666-16 · Cited by 164
Understanding diabetes in patients with HIV/AIDS
Kalra, S., Kalra, B., Agrawal, N., & Unnikrishnan, A. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-2 · Cited by 163
Sharma, A., Hill, A. N., Kurbatova, E. V., der Walt, M. L. V., Kvasnovsky, C., Tupasi, T. E., Caoili, J., Gler, M. T., Volchenkov, G. V., Kazennyy, B. Y., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30247-5 · Cited by 154
Sagor, G. H. M., Berberich, T., Takahashi, Y., Niitsu, M., & Kusano, T. (2012) · Transgenic Research · doi:10.1007/s11248-012-9666-3 · Cited by 150
The Secret Lives of Mycobacteriophages
Hatfull, G. F. (2012) · Advances in virus research · doi:10.1016/b978-0-12-394621-8.00015-7 · Cited by 149
Activation of natural killer cells by heat shock protein 70
Multhoff, G. (2002) · International Journal of Hyperthermia · doi:10.1080/0265673021000017109 · Cited by 133
Vaccinia virus in Feces and Urine of Wild Rodents from São Paulo State, Brazil
Peres, M. G., Bacchiega, T. S., Appolinário, C. M., Vicente, A. F., Mioni, M. D. S. R., Ribeiro, B., Fonseca, C., Pelícia, V. C., Ferreira, F., Abrahão, J. S., et al. (2018) · Viruses · doi:10.3390/v10020051 · Cited by 130
SANCDB: a South African natural compound database
Hatherley, R., Brown, D. K., Musyoka, T. M., Penkler, D. L., Faya, N., Lobb, K. A., & Bishop, Ö. T. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0080-8 · Cited by 129
Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480429 · Cited by 126
Self-citationCortés‐Ciriano, I., Murrell, D. S., van Westen, G. J. P., Bender, A., & Malliavin, T. E. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-014-0049-z · Cited by 118
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials
Rodríguez‐Rubio, L., Gutiérrez, D., Donovan, D. M., Martínez, B., Rodríguez, A., & García, P. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2014.993587 · Cited by 112
Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes
Sales, M. M., Campbell, C. S. G., Morais, P. K., Ernesto, C., Soares-Caldeira, L. F., Russo, P., Motta‐Santos, D., Moreira, S. R., Nakamura, F. Y., & Simões, H. G. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-1 · Cited by 112
Lai, J., Wu, B., Xuan, T., Liu, Z., & Chen, J.-Z. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-1 · Cited by 112
Hybrid Compounds as Multitarget Directed Anticancer Agents
Küçüksayan, E., & Özben, T. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160927155515 · Cited by 108
Wang, T., Liu, X.-H., Guan, J. Z., Ge, S., Wu, M., Lin, J., & Yang, L.-R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.076 · Cited by 100
Detaille, D., Vial, G., Borel, A.-L., Cottet-Rouselle, C., Hallakou-Bozec, S., Bolze, S., Fouqueray, P., & Fontaine, E. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.72 · Cited by 99
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Heinrich, N., Dawson, R., du Bois, J., Narunsky, K., Horwith, G., Phipps, A. J., Nacy, C. A., Aarnoutse, R. E., Boeree, M. J., Gillespie, S. H., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku553 · Cited by 99
McMullan, B. J., & Mostaghim, M. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.030 · Cited by 99
Tang, J., Wang, B., Wu, T. S., Wan, J., Tu, Z., Njire, M. M., Wan, B., Franzblauc, S. G., Zhang, T., Lu, X., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00176 · Cited by 97
Sellamuthu, P. S., Arulselvan, P., Kamalraj, S., Fakurazi, S., & Kandasamy, M. (2013) · ISRN Pharmacology · doi:10.1155/2013/750109 · Cited by 96
Noedl, H., Krudsood, S., Chalermratana, K., Silachamroon, U., Leowattana, W., Tangpukdee, N., Looareesuwan, S., Miller, R. S., Fukuda, M. M., Jongsakul, K., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508175 · Cited by 96
Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of type 2 Diabetes
Fouqueray, P., Leverve, X. M., Fontaine, E. M., Baquié, M., & Wollheim, C. B. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000126 · Cited by 94
Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
Geldenhuys, W. J., & der Schyf, C. J. V. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990112 · Cited by 93
Yu, X., Ye, L., Zhang, H., Zhao, J., Wang, G., Guo, C., & Shang, W. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2014.11.004 · Cited by 89
Hussein, Z. B., Wentworth, J. M., Nankervis, A. J., Proietto, J., & Colman, P. G. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06441.x · Cited by 88
Thummeepak, R., Kitti, T., Kunthalert, D., & Sitthisak, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01402 · Cited by 88
Back to the future: the 'old-fashioned' way to new medications for neurodegeneration
Lansbury, P. T. (2004) · Nature Medicine · doi:10.1038/nrn1435 · Cited by 87
The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
Wellington, S., & Hung, D. T. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00255 · Cited by 87
Isolated Compounds from Natural Products with Potential Antidiabetic Activity - A Systematic Review
Fröde, T. S., & Munhoz, A. C. M. (2017) · Current Diabetes Reviews · doi:10.2174/1573399813666170505120621 · Cited by 86
Giulia, N., Sestito, S., Digiacomo, M., & Rapposelli, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 86
Stevenson, J. C., Stresman, G. H., Gitonga, C. W., Gillig, J., Owaga, C., Marube, E., Odongo, W., Okoth, A., China, P., Oriango, R. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077641 · Cited by 82
Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides
Liu, C., Zhang, M., Hu, M., Guo, H., Li, J., Yu, Y., Jin, S. K., Wang, X., Liu, L., & Liu, X. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0502 · Cited by 77
Miller, R. S., Wongsrichanalai, C., Buathong, N., McDaniel, P. M., Walsh, D. S., Knirsch, C. A., & Ohrt, C. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.401 · Cited by 75
Donepezil: An Important Prototype to the Design of New Drug Candidates for Alzheimer’s Disease
Simoes, M. R., Viegas, F. D., Moreira, M. S., Silva, M. F., Riquiel, M. M., da Rosa, P., Castelli, M. R., dos Santos, M. H., Soares, M. G., & Viegas, C. (2014) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557513666131119201353 · Cited by 68
Self-citationNatural antimicrobial peptides against Mycobacterium tuberculosis
Abedinzadeh, M., Gaeini, M., & Sardari, S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku570 · Cited by 66
New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids
Viegas, C., Bolzani, V. D. S., Pimentel, L. S. B., Castro, N. G., Cabral, R. F., da Costa, R. S., Floyd, C., Rocha, M. S., Young, M. C. M., Barreiro, E. J., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.030 · Cited by 64
Gupta, V. K., Kumar, M., Bisht, D., & Kaushik, A. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1309440 · Cited by 58
Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes
Vuylsteke, V., Chastain, L. M., Maggu, G. A., & Brown, C. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0099-3 · Cited by 57
Samad, F., Harris, M., Puskas, C. M., Ye, M., Chia, J., Chacko, S., Bondy, G. P., Lima, V. D., Montaner, J. S., & Guillemi, S. A. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000457 · Cited by 53
Li, Q., Zhou, M., Fan, X., Yan, J., Li, W., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep28701 · Cited by 52
Zininga, T., Makumire, S., Gitau, G. W., Njunge, J. M., Pooe, O. J., Klimek, H., Scheurr, R., Raifer, H., Prinsloo, E., Przyborski, J. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135326 · Cited by 51
Self-citationRees, G., O’Hare, F., Saeed, M., Sudholz, B., Sturrock, B. A., Xie, J., Speight, J., & Lamoureux, E. L. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000307 · Cited by 50
Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids
Colín-Lozano, B., Estrada-Soto, S. E., Chávez-Silva, F., Gutiérrez-Hernández, A., Cerón‐Romero, L., Giacoman‐Martínez, A., Almanza-Pérez, J. C., Hernández‐Núñez, E., Wang, Z., Xie, X., et al. (2018) · Molecules · doi:10.3390/molecules23020340 · Cited by 50
Lin, H.-H., Zhang, L., Yan, R., Lu, J., & Yuanjia, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12061-8 · Cited by 47
Ghafouri, A., Zarrati, M., Shidfar, F., Heydari, I., Shoormasti, R. S., & Eslami, O. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0496-9 · Cited by 46
Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1
Lai, M., Liu, C., Jiang, S., Soo, P., Tu, M.-H., Lee, J., Chen, Y.-H., & Chang, K. (2015) · Molecules · doi:10.3390/molecules201019277 · Cited by 43
In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori
Makobongo, M. O., Einck, L., Peek, R. M., & Merrell, D. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068917 · Cited by 40
Min, Q., Cai, X., Sun, W., Gao, F., Li, Z., Zhang, Q., Wan, L.-S., Li, H., & Chen, J. (2017) · Scientific Reports · doi:10.1038/srep44681 · Cited by 40
Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis
Njire, M. M., Wang, N., Wang, B., Tan, Y., Cai, X., Liu, Y., Mugweru, J., Guo, J. T., Hameed, H. M. A., Tan, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-17 · Cited by 40
Neurodegenerative Diseases: Challenges And Opportunities
Cuny, G. D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.123 · Cited by 39
Human Disease and Drug Pharmacology, Complex as Real Life
Viayna, E., Sola, I., Pietro, O. D., & Muñoz‐Torrero, D. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130002 · Cited by 39
Alzheimer's Disease: Characterization, Evolution and Implications of the Neuroinflammatory Process
Viegas, F. P. D., Simões, M. C. R., da Rocha, M. D., Castelli, M. R., Moreira, M. S., & Junior, C. V. (2011) · Revista Virtual de Química · doi:10.5935/1984-6835.20110034 · Cited by 36
Self-citationOne Drug for Multiple Targets: A Computational Perspective
Méndez‐Lucio, O., Naveja, J. J., Vite‐Caritino, H., Prieto-Martínez, F. D., & Medina‐Franco, J. L. (2017) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v60i3.100 · Cited by 36
Msomi, N. Z., Shode, F. O., Pooe, O. J., Mazibuko-Mbeje, S. E., & Simelane, M. B. C. (2019) · Biomolecules · doi:10.3390/biom9100520 · Cited by 35
Self-citationLi, J., Yu, H., Wang, S., Wang, W., Chen, Q., Ma, Y., Zhang, Y., & Wang, T. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s151860 · Cited by 32
Machaba, K. E., Cobongela, S. Z. Z., Mosa, R. A., Oladipupo, L. A., Djarova, T. G., & Opoku, A. R. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-131 · Cited by 31
Self-citationSejlitz, T., & Neujahr, H. Y. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb13705.x · Cited by 30
Kuniyasu, K., Iemura, K., & Tanaka, K. (2018) · Biomolecules · doi:10.3390/biom9010010 · Cited by 27
Lawal, T. O., Adeniyi, B. A., Adegoke, O. A., Franzblau, S. G., & Mahady, G. B. (2011) · Pharmaceutical Biology · doi:10.3109/13880209.2011.625953 · Cited by 26
Opoku, F., Govender, P. P., Pooe, O. J., & Simelane, M. B. C. (2019) · Biomolecules · doi:10.3390/biom9120861 · Cited by 26
Self-citationEgan, A. M., & Vella, A. V. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1654993 · Cited by 24
Review. One Drug for Multiple Targets: A Computational Perspective
Méndez‐Lucio, O., Naveja, J. J., Vite‐Caritino, H., Prieto-Martínez, F. D., & Medina‐Franco, J. L. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 23
Dias, K. S. T., de Paula, C. T., Riquiel, M. M., do Lago, S. T. L., Costa, K. C. M., Vaz, S. M., Machado, R. P., de Lima, L. M. S., & Viegas, C. (2015) · Revista Virtual de Química · doi:10.5935/1984-6835.20150027 · Cited by 21
Mabhida, S., Mosa, R., Penduka, D., Osunsanmi, F., Dludla, P., Djarova, T. G., & Opoku, A. (2017) · Molecules · doi:10.3390/molecules22081252 · Cited by 17
Self-citationTreatment of Alzheimer's Disease: Classical Therapeutic Approach
Bajić, V., Sudar-Milovanovic, E. M., Spremo‐Potparević, B., Živković, L., Milicevic, Z., Stanimirović, J., Bogdanović, N., & Isenović, E. R. (2015) · Current Pharmaceutical Analysis · doi:10.2174/1573412911666150611184740 · Cited by 17
sRAGE and early signs of cardiac target organ damage in mild hypertensives
Maresca, A. M., Guasti, L., Bozzinì, S., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0821-5 · Cited by 15
Makhoba, X. H., Pooe, O. J., & Mthembu, M. S. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000371 · Cited by 12
Self-citationNewer oral and noninsulin therapies to treat type 2 diabetes mellitus
Hermayer, K. L., & Dake, A. W. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.04 · Cited by 6
Cited by
Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 306
RetractedNetwork pharmacology: a crucial approach in traditional Chinese medicine research
Zhai, Y., Liu, L., Zhang, F., Chen, X., Wang, H., Zhou, J., Chai, K., Liu, J., Lei, H., Lu, P., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-024-01056-z · Cited by 260
Gunter, N. V., Teh, S. S., Lim, Y. M., & Mah, S. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.594202 · Cited by 91
Stevenson, G. A., Kirshner, D., Bennion, B. J., Yang, Y., Zhang, X., Zemla, A., Torres, M. W., Epstein, A., Jones, D., Kim, H., et al. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00722 · Cited by 7
Metadata
- Authors
- Makhoba, X. H., Viegas Jr., C., Mosa, R. A., Viegas, F. P., & Pooe, O. J.
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-08
- Volume
- Volume 14
- Pages
- 3235-3249
- ISSN
- 1177-8881 (ISSN-L)
- OpenAlex
- W3047739104
- Cited by
- 321
- References
- 114
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.